GLP-1's as low as $89. Get Started.
1 in 8 adults are on a GLP-1
Learn More
Our Business
Products
Menu
Semaglutide vs. Tirzepatide: How They Differ and How Providers Choose
By Our Editorial Team
If you’ve spent any time researching GLP-1 medications, two names keep showing up: semaglutide and tirzepatide. They get mentioned together so often that it’s easy to assume they’re interchangeable. They’re closely related, but they work a little differently, and those differences can shape which one a provider recommends. This guide to semaglutide vs. tirzepatide covers how they differ, how providers choose between them, what the research shows, and which side effects to expect.
Use it to prepare for a better conversation with your provider. The final decision should come from someone who knows your health history.
Quick Answer
Semaglutide and tirzepatide are both prescription medications used in provider-guided weight management, and both are commonly taken as once-weekly injections. Semaglutide activates one appetite-related hormone pathway (GLP-1), while tirzepatide activates two (GLP-1 and GIP). In a head-to-head trial, tirzepatide produced greater average weight loss, though individual results vary. Side effects are similar and mostly digestive. A licensed provider decides which one fits you.
Key Takeaways
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 receptor agonist, the first approved medication of its kind.
This guide compares the once-weekly injectable versions. Both start at a low dose that increases gradually.
In the SURMOUNT-5 trial, average weight loss after 72 weeks was 20.2% with tirzepatide and 13.7% with semaglutide. Individual results vary.
The most common side effects for both are digestive, such as nausea, diarrhea, and constipation, and they’re often most noticeable during dose increases.
Neither medication is right for everyone. A licensed provider reviews your history, current medications, and goals before prescribing either one.
What Are Semaglutide and Tirzepatide?
Both medications work with incretin hormones. These are hormones your gut releases after you eat, and they help signal fullness and regulate blood sugar. The medications mimic those natural signals but stay active in the body far longer than the hormones themselves.
Semaglutide
Semaglutide is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) helps you feel full sooner, slows how quickly your stomach empties, and supports blood sugar regulation after meals. In everyday terms, many people find they think about food less and feel satisfied with smaller portions.
Semaglutide is the active ingredient in the brand-name medications Ozempic, which is approved for type 2 diabetes, and Wegovy, which is approved for chronic weight management. Semaglutide also comes in tablet form. This guide focuses on the once-weekly injections, since those are what head-to-head research has compared.
Tirzepatide
Tirzepatide activates the GLP-1 receptor too, plus a second one: the receptor for GIP (glucose-dependent insulinotropic polypeptide). GIP also plays a role in how the body processes food and manages blood sugar. Researchers believe acting on both pathways may help explain the differences seen in clinical trials, though the exact mechanisms are still being studied.
Tirzepatide is the active ingredient in Mounjaro, which is approved for type 2 diabetes, and Zepbound, which is approved for chronic weight management.
What About Compounded Versions?
Compounded medications are prepared by licensed pharmacies for individual patients, generally when a patient has a medical need that an FDA-approved product can’t meet. Compounded semaglutide and tirzepatide are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness, or quality before they reach patients.
There are also legal limits on when these medications can be compounded. Now that the national shortages of semaglutide and tirzepatide have been resolved, the FDA has clarified its policies on compounding copies of the approved products. Your provider can explain whether a compounded option is appropriate and available for your specific needs. For more background, see the FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
Semaglutide vs. Tirzepatide at a Glance
Here’s a side-by-side look at the main differences.
Semaglutide | Tirzepatide | |
How it works | Activates GLP-1 receptors | Activates GLP-1 and GIP receptors |
Form compared here | Once-weekly injection | Once-weekly injection |
Starting approach | Low dose, increased gradually | Low dose, increased gradually |
Brand names | Ozempic, Wegovy | Mounjaro, Zepbound |
Average weight loss in SURMOUNT-5 | 13.7% at 72 weeks | 20.2% at 72 weeks |
Common side effects | Nausea, diarrhea, constipation, vomiting | Similar digestive side effects |
Who decides | A licensed provider | A licensed provider |
Is Tirzepatide More Effective Than Semaglutide?
This is the question most people are really asking, so let’s take it head-on. A 2025 head-to-head clinical trial called SURMOUNT-5 compared once-weekly injectable tirzepatide and semaglutide in adults with obesity who did not have type 2 diabetes. After 72 weeks, participants taking tirzepatide lost an average of 20.2% of their starting body weight, compared with 13.7% for those taking semaglutide.
That’s a meaningful difference, and it comes with important context:
Averages describe groups, not individuals. Some people respond very well to semaglutide, and some people find tirzepatide harder to tolerate.
The trial tested specific doses under controlled conditions. Results in everyday life can look different.
Stronger on average doesn’t automatically mean better for you. Tolerance, health conditions, cost, and access all matter.
Daily habits still count. In clinical trials, both medications were studied alongside nutrition and activity guidance.
So the honest answer: tirzepatide has shown greater average weight loss in research, and semaglutide remains a well-studied, widely used option. The best choice is one that fits your health needs and that you can stick with.
What Side Effects Should You Expect?
Semaglutide and tirzepatide have similar side effect profiles. The most common ones are digestive:
Nausea
Diarrhea or constipation
Vomiting
Bloating, indigestion, or burping
Reduced appetite, which is part of how the medications work but can make it harder to get enough protein and fluids
These effects tend to be most noticeable when you start or move up to a higher dose, and many people find they ease over time. That’s one reason providers increase doses gradually. For the complete list, see the prescribing information in the sources below.
Simple Habits That Can Help
Eat smaller meals and stop when you feel full.
Slow down at meals so your body can register fullness.
Go easy on greasy, fried, or very rich foods.
Keep up with fluids throughout the day.
Prioritize protein to help protect muscle while you’re eating less.
When to Call Your Provider
Contact your provider promptly if:
Nausea, vomiting, or diarrhea makes it hard to eat or drink normally, or lasts more than a few days.
You notice signs of dehydration, such as dizziness, very dark urine, or urinating much less than usual.
Constipation or heartburn is getting worse instead of better.
You’re unsure whether a new symptom is related to your medication.
When to Seek Emergency Care
Get emergency medical care right away if you have:
Severe stomach pain that won’t go away, with or without vomiting, which can be a sign of pancreatitis.
Severe pain in the upper right abdomen, fever, or yellowing of the skin or eyes, which can signal gallbladder problems.
Signs of a serious allergic reaction, such as swelling of the face, lips, tongue, or throat, trouble breathing or swallowing, or a very fast heartbeat.
Who Should Not Take Semaglutide or Tirzepatide?
A provider will review your health history before prescribing either medication. Some situations rule these medications out entirely, while others call for extra caution.
When These Medications Aren’t an Option
A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Both medications carry a boxed warning about thyroid C-cell tumors.
A previous serious allergic reaction to the medication or any of its ingredients.
When Extra Caution Is Needed
These don’t automatically rule treatment out, but your provider will want to discuss them with you:
A history of pancreatitis or gallbladder disease
Kidney problems, since dehydration from digestive side effects can strain the kidneys
Severe digestive conditions, such as gastroparesis (very slow stomach emptying)
Diabetic eye disease, if you have type 2 diabetes
A history of depression or suicidal thoughts
Other medications you take, especially insulin or other diabetes medications that can lower blood sugar
Pregnancy, Breastfeeding, and Birth Control
These medications are not recommended during pregnancy. If you’re planning to become pregnant, talk with your provider well ahead of time. For semaglutide, the Wegovy prescribing information advises stopping at least two months before a planned pregnancy, because the medication stays in the body for several weeks. If you’re breastfeeding, discuss it with your provider before starting either medication.
One important difference: tirzepatide may reduce the effectiveness of birth control pills. If you use oral hormonal contraception, your provider may recommend switching to a non-oral method or adding a barrier method for four weeks after starting tirzepatide and for four weeks after each dose increase.
How Do Providers Choose Between Semaglutide and Tirzepatide?
There isn’t a universal winner in the semaglutide vs. tirzepatide decision. Providers usually weigh several factors together.
Your Health History
Existing conditions, past reactions to medications, and current prescriptions all shape what’s appropriate for you.
Your Goals
Someone focused mainly on weight management may have a different conversation than someone who is also working on blood sugar.
Your Experience So Far
If you’ve already taken one of these medications, how you responded and how well you tolerated it are useful information.
Practical Factors
Cost, coverage, and availability are real parts of the decision. A plan that’s hard to afford is hard to stick with, and consistency matters.
Can You Switch From Semaglutide to Tirzepatide?
Yes. People switch for different reasons: wanting a different response, managing side effects, or cost and availability. Switching should always happen under provider guidance. Your provider will decide your starting dose on the new medication and how quickly to adjust it, often starting lower to help limit side effects.
Questions to Ask Your Provider
Based on my health history, is semaglutide or tirzepatide a better starting point for me?
What side effects should I watch for, and what should I do if they happen?
How will my dose be adjusted over time?
Do any of my current medications or conditions affect my options?
If a compounded medication is part of my plan, which pharmacy prepares it, and how is it tested?
What should I focus on with food and activity to support my treatment?
How will we track my progress?
Frequently Asked Questions
Is tirzepatide stronger than semaglutide?
In the SURMOUNT-5 trial, tirzepatide led to greater average weight loss than semaglutide: 20.2% versus 13.7% of starting body weight over 72 weeks. That doesn’t make it the better choice for everyone. Some people respond well to semaglutide or tolerate it better, and health history, cost, and access also matter.
Which has fewer side effects, semaglutide or tirzepatide?
Their side effects are similar. Both most commonly cause digestive symptoms like nausea, diarrhea, and constipation, especially during dose increases. How you personally tolerate each one can differ, which is one reason providers start low and adjust gradually. If side effects are hard to manage, talk with your provider before changing anything on your own.
Are semaglutide and tirzepatide the same as Ozempic and Mounjaro?
Semaglutide is the active ingredient in Ozempic and Wegovy, and tirzepatide is the active ingredient in Mounjaro and Zepbound. Those are brand names from specific manufacturers. Compounded semaglutide and tirzepatide are prepared by licensed pharmacies, are not FDA-approved, and aren’t identical to the branded products.
Do you still need to change your diet on these medications?
Yes, nutrition still matters. Both medications reduce appetite, which makes it more important to choose foods that support your body, especially protein, fiber, and fluids. In clinical trials, both were studied alongside lifestyle guidance. The medication works best as support that makes healthy routines easier to keep.
The Bottom Line
Semaglutide and tirzepatide are closely related, with one key difference: tirzepatide acts on two hormone pathways instead of one. In head-to-head research, once-weekly injectable tirzepatide produced greater average weight loss, but the right choice depends on your health history, how you tolerate treatment, and what’s practical for your life.
If you’re weighing your options, Trava’s licensed providers can review your health history and talk through whether semaglutide, tirzepatide, or another approach makes sense for you. It starts with a short online assessment.
Sources and References
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). The New England Journal of Medicine, 2025.
Wegovy (semaglutide) Prescribing Information. DailyMed, U.S. National Library of Medicine.
Zepbound (tirzepatide) Prescribing Information. DailyMed, U.S. National Library of Medicine.
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration.
FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. U.S. Food and Drug Administration.
Last reviewed: November 2026
Disclaimer: Trava is not affiliated with Mounjaro, Ozempic, Rybelsus, Saxenda, Trulicity, Wegovy, or Zepbound. However, we do offer alternatives such as Semaglutide and Tirzepatide. Before beginning any treatment, it’s essential to consult with a licensed healthcare provider to ensure the best approach for your individual health needs.
